top of page
HELIOS-BD: Lithium's mechanism in bipolar disorder - investigating the light hypersensitivity hypothesis
Funder: Wellcome Trust (£3.5m)
Project duration: 2023-2028
Principal Investigator: Prof Daniel Smith, University of Edinburgh
Collaborating Institutions: University of Edinburgh, Newcastle University, Northumbria University, Technical University Munich
Project website: Helios-BD
Our primary hypothesis is that lithium is effective in bipolar disorder because it reduces hypersensitivity to evening light, making individuals less vulnerable to light-induced circadian disruption. If correct, this discovery will back-translate into more precise sub-phenotyping of early-stage bipolar disorder and new and more targeted chronotherapy approaches. We will test:
the extent to which individuals with bipolar disorder are hypersensitive to the effects of evening light
whether lithium works via a mechanism that decreases retinal sensitivity to light-induced circadian disruption
whether there is a microstructural basis in the retina for this hypersensitivity and its attenuation by lithium therapy.
These questions will be addressed at multiple levels of explanation across six complementary workstreams.
bottom of page